News

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Agilent Technologies, Inc. (NYSE:A) and set a price target of ...
On May 29, 2025, Stifel analysts reiterated their Buy rating and $550 price target for Synopsys, Inc. (NASDAQ:SNPS) shares.
On May 24, analysts at Stifel reaffirmed their Buy rating and price target of $48 for Bicara Therapeutics Inc. (NASDAQ:BCAX).
GAMMA Investing LLC now owns 4,446 shares of the company’s stock valued at $41,000 after buying an additional 1,225 shares during ... research reports. Stifel Nicolaus dropped their target ...
Stifel Nicolaus analyst Simon Yarmak maintained a Buy rating on Pebblebrook Hotel (PEB – Research Report) today and set a price target of $16.50. The company’s shares closed yesterday at $11.75.
Insulet (NASDAQ:PODD – Get Free Report) had its price target hoisted by equities research analysts at Stifel Nicolaus from $245.00 to $293.00 in a research note issued on Friday,Benzinga reports.
Stifel's broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners and Miller Buckfire & Co., LLC business divisions; Keefe, ...
Stifel Nicolaus analyst Rick Wise maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $87.00. The company’s shares closed yesterday at $85.00.
Toronto-based Stifel Nicolaus Canada Inc. has agreed to pay the Canadian Investment Regulatory Organization (CIRO) a $475,000 fine for sharing potentially confidential information with clients.
Stifel Nicolaus will move the 40 or so employees in its office near 48th and Main streets to a building on the Country Club Plaza, where it will occupy about 12,500 square feet starting Dec. 18.